Cargando…
A case of primary metastatic glassy cell carcinoma of the uterine cervix that responded to combined docetaxel and carboplatin()
• Glassy cell carcinoma (GCC) of the cervix is rare and aggressive. • A few case reports have described a response to intravenous chemotherapy for this malignancy. • This is the first report of a GCC case that responded to a combination of docetaxel and carboplatin.
Autores principales: | Ukita, Yuji, Tsubamoto, Hiroshi, Kato, Toru, Suno, Shigeo, Shibahara, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862296/ https://www.ncbi.nlm.nih.gov/pubmed/24371710 http://dx.doi.org/10.1016/j.gynor.2013.07.004 |
Ejemplares similares
-
Advanced papillary serous carcinoma of the uterine cervix: a case with a remarkable response to paclitaxel and carboplatin combination chemotherapy
por: Ueda, Masashi, et al.
Publicado: (2011) -
Complete Response of Recurrent Small Cell Carcinoma of the Uterine Cervix to Paclitaxel, Carboplatin, and Bevacizumab Combination Therapy
por: Nakao, Yuri, et al.
Publicado: (2020) -
Pazopanib-mediated long-term disease stabilization after resection of a uterine leiomyosarcoma metastasis to the brain: A case report
por: Inoue, Kayo, et al.
Publicado: (2016) -
Cytomorphological characteristics of glassy cell carcinoma of the uterine cervix: histopathological correlation and human papillomavirus genotyping
por: Jung, Yoon Yang, et al.
Publicado: (2016) -
Clinical outcomes of advanced-stage glassy cell carcinoma of the uterine cervix: a need for reappraisal
por: Yoon, Nara, et al.
Publicado: (2016)